K

Researcher Profile

Kimberly Workowski

3

Publications

392

Citations

10

Co-Authors

3

Active Years

Publications

Journal Article The Lancet HIV Aug 01, 2023

Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial

Onyema Ogbuagu · Sorana Segal-Maurer · Winai Ratanasuwan · Anchalee Avihingsanon +43 more

10.1016/s2352-3018(23)00113-3 65 citations

Open Access Journal Article The Lancet Infectious Diseases Aug 01, 2020

Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction

Arlene C Seña · Laura Bachmann · Christine Johnston · Teodora Wi +5 more

10.1016/s1473-3099(20)30171-7 34 citations

Journal Article The Lancet Nov 01, 2017

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Paul E Sax · Anton Pozniak · M Luisa Montes · Ellen Koenig +12 more

10.1016/s0140-6736(17)32340-1 293 citations

Publication Timeline

2023

1

2020

1

2017

1

Frequent Co-Authors

Hans-Jürgen Stellbrink

Andrea Antinori

Daniel S. Berger

Joseph Custodio

Francesco Castelli